Myocarditis after COVID-19 vaccines remain rare, highest risk in young males
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was…
A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was…
In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of…